 |
 |
 |
FDA
Home Page | Search FDA Site |
FDA A-Z Index | Contact Dockets
Documents and comments received by the Division of Dockets Management may be posted
on the Internet. Please do not include personal
identifying information, i.e. date of birth, social security number, medical
information, etc., in your correspondence.
Submit Electronic Comments
Documents are on display for public inspection at the Division of Dockets Management, 5630 Fishers Lane (Room 1061), HFA-305, Rockville, MD, 20852; 301-827-6860; TTY/TDD Users 1-800-735-2258.
Docket No. FDA-2008-N-0163 (formerly Docket No. 2001N-0067), CDRH 20087. Dental Devices: Classification of Encapsulated Amalgam Alloy and Dental Mercury and Reclassification of Dental Mercury; Issuance of Special Controls for Amalgam Alloy; Reopening of Comment Period. Pages 22877-22879 [FR Doc. 08–1187] [TXT] [PDF] [PRE-PUB] Comments due July 28, 2008
Docket No. FDA-2008-D-0233, CBER 200722. Draft Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion and Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Availability. Pages 22958-22959 [FR Doc. E8–9253] [TXT] [PDF] [PRE-PUB] Comments due July 28, 2008
Docket No. FDA-2007-N-0154 (formerly Docket No. 2007N-0444), OC 200893. Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Recordkeeping and Records Access Requirements for Food Facilities. Page 22951 [FR Doc. E8–9155] [TXT] [PDF] [PRE-PUB] OMB control number 0910-0560 Expires March 31, 2011
Docket No. FDA-2008-N-0240, OC 2008. Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals. Pages 22951-22955 [FR Doc. E8–9157] [TXT] [PDF] [PRE-PUB] Comments due June 27, 2008
Docket No. FDA-2008-N-0239, OC 200897. Agency Information Collection Activities; Proposed Collection; Comment Request; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring. Pages 22955-22956 [FR Doc. E8–9159] [TXT] [PDF] [PRE-PUB] Comments due June 27, 2008
OC 200878. Cooperative Agreement to Support the World Health Organization International Programe on Chemical Safety. Pages 22956-22958 [FR Doc. E8–9251] [TXT] [PDF] [PRE-PUB]
Docket No. FDA-2008-N-0238, CDER 200810. Determination That TAPAZOLE Tablets and 18 Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness. Pages 22960-22961 [FR Doc. E8–9161] [TXT] [PDF] [PRE-PUB]
Docket No. FDA-2008-N-0226, OC 200884. Risk Communication Advisory Committee; Notice of Meeting. Pages 22959-22960 [FR Doc. E8–9177] [TXT] [PDF] [PRE-PUB] Meeting on May 15, 2008 and May 16, 2008 Comments due June 16, 2008
Docket No. 2004N-0018, CDER 200482. Human Subject Protection; Foreign Clinical Studies Not Conducted Under an Investigational New Drug Application. Pages 22800-22816 [FR Doc. E8–9200] [TXT] [PDF] [PRE-PUB] Effective date October 27, 2008
Table of Contents for Entire Federal Register
Monday, April 28, 2008
(TXT)
(PDF)